Title	Publication Date	Language	Citations
Measuring Health-Related Quality of Life in Leukemia: The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire	2012/12/01	English	98
Estimating Population-Based Values for EQ-5D Health States in Thailand	2011/12/01	English	98
The Inclusion of Informal Care in Applied Economic Evaluation: A Review	2012/09/01	English	98
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward	2017/03/01	English	98
Predicting Adherence to Medications Using Health Psychology Theories: A Systematic Review of 20 Years of Empirical Research	2014/12/01	English	97
Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group	2012/12/01	English	96
The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects	2009/03/01	English	95
Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model	2009/03/01	English	95
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report	2019/03/01	English	95
Measurement of HRQL Using EQ-5D in Patients with Type 2 Diabetes Mellitus in Japan	2006/01/01	English	94
General Population Reference Values for the French Version of the EuroQol EQ-5D Health Utility Instrument	2010/07/01	English	94
Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities	2002/03/01	English	94
Hypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of Life and Health Burden	2009/07/01	English	94
Economic Burden of Patients with Anemia in Selected Diseases	2005/11/01	English	94
Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force	2017/01/01	English	93
Patient-Reported Outcomes: Instrument Development and Selection Issues	2007/11/01	English	93
Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions	2012/05/01	English	93
The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization	2016/01/01	English	93
Toward a Consensus on the QALY	2009/03/01	English	93
Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?	2012/07/01	English	92
Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability	2005/01/01	English	92
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report	2018/10/01	English	92
Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available	2011/06/01	English	91
Mapping the Cancer-Specific EORTC QLQ-C30 to the Preference-Based EQ-5D, SF-6D, and 15D Instruments	2009/11/01	English	91
Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs)	2015/06/01	English	91
Modeling Length of Stay in Hospital and Other Right Skewed Data: Comparison of Phase-Type, Gamma and Log-Normal Distributions	2009/03/01	English	91
Prospective Validation of Eight Different Adherence Measures for Use with Administrative Claims Data among Patients with Schizophrenia	2009/09/01	English	90
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward	2019/11/01	English	89
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003	2011/01/01	English	89
The Effect of Perceived Health Status on Patient Satisfaction	2008/07/01	English	89